Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validity.
Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validity.
复制标题
DOI:
10.1111/gbb.12268
复制
发表时间:
2016-01
期刊:
影响因子:
--
通讯作者:
Young JW
中科院分区:
文献类型:
--
作者:
Cope ZA;Powell SB;Young JW
Numerous psychiatric disorders whose cognitive dysfunction links to functional outcome have neurodevelopmental origins including schizophrenia, autism, bipolar disorder, etc.. Treatments are needed for these cognitive deficits, which require development using animal models. Models of neurodevelopmental disorders are as varied and diverse as the disorders themselves, recreating some but not all aspects of the disorder. This variety may in part underlie why purported pro-cognitive treatments translated from these models have failed to restore functioning in the targeted patient populations. Further complications arise from environmental factors used in these models also contribute to numerous disorders and so perhaps impact only specific domains, with diagnostic boundaries defining individual disorders limiting translational efficacy. The Research Domain Criteria (RDoC) project seeks to “develop new ways to classify mental disorders based on behavioral dimensions and neurobiological measures” in hopes of facilitating translational research by remaining agnostic towards diagnostic borders derived from clinical presentation in humans. Models could therefore recreate biosignatures of cognitive dysfunction irrespective of disease state. This review highlights work within the field of neurodevelopmental models of psychiatric disorders tested in cross-species translational cognitive paradigms that directly inform this newly developing research strategy. By expounding on this approach, the hopes are that a fuller understanding of each model may be attainable in terms of the cognitive profile elicited by each manipulation. Hence, conclusions may begin to be drawn on the nature of cognitive neuropathology on neurodevelopmental and other disorders, increasing the chances of pro-cognitive treatment development for individuals affected in specific cognitive domains.